Kellogg’s to cut wheat, oats treated with Bayer’s Roundup herbicide from supply chain by 2025

e A child eating Kelloggs c

Kellogg’s, the multinational food manufacturer based in Battle Creek, Mich., is taking a stand.

But very quietly.

At the end of 2019, the company made a commitment to phase out by 2025 wheat and oats on which farmers have used glyphosate as a drying agent, according to Kellogg’s chief sustainability officer Amy Senter. Glyphosate is the active ingredient in Roundup, the Bayer-Monsanto weedkiller that is the most heavily used herbicide in the United States.

Although this practice is not widespread in Kellogg’s wheat and oat supply chains, the company said in a post on its Open for Breakfast website that “we are working with our suppliers to phase out using glyphosate as pre-harvest drying agent in our wheat and oat supply chain in our major markets.” That includes Britain, France, the United States, Canada, Mexico and Australia.

But Kellogg’s neglected to tell the industry groups that support wheat and oat growers, said Caitlin Eannello, the director of communications for the National Association of Wheat Growers.

“We heard something [about it] this morning but didn’t realize this was in the works on their end ….”

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.